Evidence
Scientific Papers and Literature:
Recently there has been an explosion of evidence presented in the literature to support the empirical data that this type of surgery eliminates Type 2 diabetes:
Presented below is some of the recent evidence that gastric bypass surgery has a dramatic effect on diabetes.
Click on the links below to view the citations in another window.
Cell Metabolism Experimental evidence of glucose metabolism changes following gastric bypass surgery, in animals.
Daily Mail Interview with Carel le Roux from Imperial College London. He describes the effect of gastric bypass surgery on diabetic patients.
The Guardian An article calling for the consideration of patients with diabetes to be offered gastric bypass surgery.
Medscape A review article on gastric bypass surgery for the treatment of Type 2 diabetes.
NHS Economic Evaluation Database Evaluation of the cost benefit of gastric bypass surgery for weight loss.
Science Daily Recent review of the treatment of Type 2 diabetes by gastric bypass surgery.
Diabetes Care A paper presenting the effects of bypass surgery on diabetic patients.
Mayo Clinic Information for patients having had gastric bypass surgery for obesity.
BMJ Review A review of gastric bypass surgery along with citations.
Mayo Clinic review paper Follow up study of patients following gastric bypass surgery.
Minnesota Centre report of gastric bypass surgery on the effect of the endocrine status of patients.
Journal of Gastrointestinal Surgery A review of diabetic patients following gastric bypass surgery.
International Federation for Surgery of Obesity and Metabolic Diseases Sleeve Gastrectomy Versus Mini-Gastric Bypass for the Treatment of Non-Morbid Obese Diabetic Patients.
International Federation for Surgery of Obesity and Metabolic Diseases Laparoscopic Mini-Gastric Bypass versus Roux-En-Y Gastric Bypass: 5-Year Results and Final Report of a Randomized Trial.
International Federation for Surgery of Obesity and Metabolic Diseases Sleeve Gastrectomy Versus Mini-Gastric Bypass for the Treatment of Non-Morbid Obese Diabetic Patients: a Randomized Trial.